Search
for
Sort by
Research 61–90 of 1000+
- An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
- Combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent girls
- Treatment of moderate-to-severe alopecia areata in pre-adolescent children with baricitinib
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Upadacitinib for the management of severe alopecia areata in adolescent patients: a single-centre retrospective study
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics
- Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
- Global, regional, and national burden of alopecia areata in adolescents and young adults aged 10–24 years from 1990 to 2021: a trend analysis
- From Bald to Bold: Reversal of Alopecia Totalis in an Adolescent Using Dupilumab Monotherapy
- A Systematic Literature Review of Alopecia Areata in Children and Adolescents: Psychosocial Impact
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- Environmental stress but not subjective distress in children or adolescents with alopecia areata
- A Plain Language Summary on Ritlecitinib Treatment for Adults and Adolescents with Alopecia Areata
- Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study
- Content validity of five single‐item instruments in adolescents with alopecia areata
- Efficacy and Safety of Oral Janus Kinase Inhibitors in Adults and Adolescents with Alopecia Areata: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Patient Considerations when Using Ritlecitinib for Alopecia Areata in Adolescents: Guidance for the Clinicians
- Predictors of Vitamin D Insufficiency in Children and Adolescents With Alopecia Areata
- Upadacitinib for Severe Alopecia Areata in Adults and Adolescents
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in Adults and Adolescents with Alopecia Areata
- Complete Reversal of Extensive Alopecia areata Progressing to Alopecia totalis in an Adolescent Male: A Homeopathic Case Treated at Dr Batra’s® Homeopathy Clinic
- Global, Regional, and National Burden of Alopecia Areata in Children and Adolescents Aged 0-19 years from 1990 to 2021 and Projection to 2040
- Moth-eaten alopecia as a sole manifestation of secondary syphilis in an adolescent: Role of a dermatologist
- La FDA aprueba Litfulo® (ritlecitinib) para el tratamiento de la alopecia areata grave en adolescentes y adultos
- S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents
- Oral Tofacitinib for the Management of Moderate to Severe Alopecia Areata in Children and Adolescents: A Retrospective Study of 36 Patients
- Treatment Options for Alopecia Areata in Children and Adolescents
- Integrated Safety Analysis of Ritlecitinib in Adolescent Patients with Alopecia Areata from the Randomized, Placebo-Controlled ALLEGRO Phase 2b/3 and Ongoing Open-Label Phase 3 ALLEGRO-LT Studies